Mark N. Lampert, Director: Olema Pharmaceuticals OLMA Buy · Filed 23/09/14

Trade details

Type: Insider buy
Amount: $7,628,735.52
Shares · price: 775,278 sh · $9.84 a share
Held after: 4,688,954 sh
Stock: Olema Pharmaceuticals OLMA
Person: Mark N. LampertDirector
Trade date: 23/09/12
Filed: 23/09/14
Days to filing: 2 days

11 insiders bought this week

Insiders buying this week: 11 insiders
Holding change: +19.8%

Olema Pharmaceuticals trades, last 26 weeks

What else happened in Olema Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/08/13~23/10/12

Mark N. Lampert's recent trades

Mark N. LampertDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$89.2M
837,914 sh
$89.2M
Filed 06/26
Traded 06/26
Mark N. LampertDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$66.8M
627,597 sh
$66.8M
Filed 06/26
Traded 06/26
Mark N. LampertDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$12.1M
113,289 sh
$12.1M
Filed 06/26
Traded 06/26
Mark N. LampertDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$5.5M
51,858 sh
$5.5M
Filed 06/26
Traded 06/26
Mark N. LampertDirector
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$32.4M
1,932,354 sh
$32.4M
Filed 04/02
Traded 03/31

Mark N. Lampert, Director — bought $7.6M of Olema Pharmaceuticals OLMA · 775,278 sh @ $9.84 | Whalegun